NCT01155583 · OUTCOME

CD34+ Cell Yield and Time to Neutrophil and Platelet Recovery

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma · Source last updated 2020-11-16

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: after cycle 1 (28 days)

What was measured

CD34+ cell yield will be calculated based on flow cytometry of mononuclear cells harvested following stem cell mobilization. Time to neutrophil (\> 1,000/mm3) and platelet (\> 100,000/mm3) recovery will be counted from the day of stem cell infusion (=day 0)

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: CD34+ cell yield will be calculated based on flow cytometry of mononuclear cells harvested following stem cell mobilization. Time to neutrophil (\> 1,000/mm3) and platelet (\> 100,000/mm3) recovery will be counted from the day of stem cell infusion (=day 0)
reporting Status: NOT_POSTED
time Frame: after cycle 1 (28 days)
title: CD34+ Cell Yield and Time to Neutrophil and Platelet Recovery
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice